samedan logo
 
 
spacer
home > ict > spring 2018 > clinical navigation
PUBLICATIONS
International Clinical Trials

Clinical Navigation

Over the last decade within pharmacovigilance, significant developments and improvements to regulations have been made. With the revision of regulations occurring within multiple countries and regions, the pressure on sponsors/marketing authorisation holders (MAHs) to be knowledgeable of and abide by these is an ongoing challenge. Outsourcing different tasks and responsibilities is one available option. CROs are often able to provide sponsors (and/or MAHs within said sponsors) with greater global reach through coverage in multiple countries and take a proactive approach to remain knowledgeable on the current pharmacovigilance regulations to properly advise sponsors. Furthermore, CROs not only have the ability to advise sponsors, but also the skills, processes, systems, and resources to be able to adhere to this continually changing and costly environment, while still providing a high-quality service and maintaining compliance.

A shift in dynamic has been marked from the typical clientcontractor relationship, where sponsors may now see CROs as their collaborative partner and, essentially, an extension of their company. CROs must recognise that each sponsor may have different needs and expectations and therefore appreciate the need to be flexible, while still remaining compliant with all regulations as the ultimate responsibility for pharmacovigilance activities remain with the sponsor. However, the willingness of sponsors to listen to advice from CROs and make informed decisions on best practice means that they remain compliant. This article will explore several instances where CRO support may be required by sponsors.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Nick Barker is a Director of Clinical Safety for Medpace, working closely with sponsors to support adherence to regulations. He has experience in pharmacovigilance across all clinical trial phases for various indications, as well as post-marketing. Nick’s key interests lie in the translation of regulations into processes, through the development of procedures and process improvements.

Katharine Colbert RN, BSN, MSBM, MPH, is a Senior Safety Manager at Medpace with a strong clinical background in paediatric oncology/stem cell transplant. With 17 years of industry experience, she has extensive global knowledge in various therapeutic areas within both clinical safety and post-marketing pharmacovigilance.
spacer
Nick Barker
spacer
spacer
spacer
Katharine Colbert
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

RSSL introduces same-day mycoplasma testing service in UK

Reading Scientific Services Ltd (RSSL), a leading provider of scientific and technical solutions to the global biopharmaceutical, pharmaceutical, and biopharmaceutical sectors, has introduced the United Kingdom’s first same-day mycoplasma testing service for manufacturers of biologic medicines.
More info >>

White Papers
 
Industry Events

World Pharma Week 2019

17-20 June 2019, Seaport World Trade Center, Boston

World Pharma Week will bring together a unique and international mix of large and medium pharmaceutical and biotech companies, CROs, leading universities and clinical research institutions, emerging companies and tool providers—making it a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement